CSF1R and myeloid sarcoma: Together, these data suggest that CSF1R may represent a key signaling node by which we can therapeutically modulate the proliferation and molecular identity of disease-associated microglia thereby reducing deleterious neuroinflammation and neurodegeneration in progressive MS.